Pittsburgh, PA, United States of America

Li Wan

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Carnegie Mellon University, University of Pittsburgh. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Li Wan. Retrieved from https://idiyas.com/inventor/li-wan-ckmajcgj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Li Wan in Drug Screening Technology

Introduction

Li Wan is an accomplished inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of drug screening technology. His innovative work focuses on developing methods and systems that enhance the efficacy and safety of therapeutic agents.

Latest Patents

Li Wan holds a patent for a "System and method for screening therapeutic agents." This patent describes a drug screening device that provides a method for determining optimal drug concentrations and efficacy in patients. Additionally, it outlines a method for identifying effective chemotherapeutic drugs and their concentrations. The device also facilitates the assessment of drug safety and efficacy.

Career Highlights

Throughout his career, Li Wan has worked with prestigious institutions such as Carnegie Mellon University and the University of Pittsburgh. His experience in these research environments has allowed him to develop and refine his innovative ideas in drug screening technology.

Collaborations

Li Wan has collaborated with various professionals in his field, including Carola Neumann, who has contributed to his research endeavors.

Conclusion

Li Wan's contributions to drug screening technology exemplify the impact of innovation in the medical field. His patent and collaborative efforts highlight the importance of developing effective therapeutic agents for patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…